Over the past decade, healthcare has slowly been moving from a focus on volume to value based healthcare. With the COVID-19 pandemic, compelling aspects of alternative payment models (APM) are causing providers, payers, and pharmaceutical manufacturers to take notice. Precision’s Elizabeth Oyekan identifies four emerging trends in APM practices that are enabling APMs to be better prepared to deliver high-quality and more affordable care during the COVID-19 pandemic.
Read the full article here!
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
